The present invention relates to compounds which inhibit the protein product Ras of the proto-oncogene ras, more particularly Ras-effector interaction, by stabilizing conformational state 1(T) of Ras GTP having a decreased effector affinity. It further relates to the use of these compounds as medicaments and anti-tumor agents and to pharmaceutical compositions comprising such compounds.
本发明涉及通过稳定具有较低效应亲和力的 Ras GTP 的构象态 1(T)来抑制原癌
基因 ras 的蛋白产物 Ras,特别是 Ras-效应相互作用的化合物。本发明还涉及这些化合物作为药物和抗肿瘤剂的用途,以及包含这些化合物的药物组合物。